Volume 22, Number 9—September 2016
Research
Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge
Table
Antibiotic susceptibility of enterohemorrhagic Escherichia coli O80:H2 and O157:H7 isolates used in an antibiotics assay, France, January 2005–October 2014
Isolate (source) |
Serotype |
MIC, µg/mL |
||
---|---|---|---|---|
Azithromycin |
Ciprofloxacin |
Ceftriaxone |
||
35344 (stool) | O80:H2 | 1 | 0.5 | 0.25 |
35431 (blood) | O80:H2 | 16 | 0.5 | 0.06 |
33115 (pancreas) | O80:H2 | 16 | 0.25 | 0.06 |
36047 (stool) | O80:H2 | 16 | 0.06 | 0.06 |
EDL933 (ground beef) | O157:H7 | 32 | 0.12 | 0.12 |
Page created: August 16, 2016
Page updated: August 16, 2016
Page reviewed: August 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.